반응식
[C:1]([C:5]1[CH:6]=[C:7]([NH:11][C:12]([C:14]2([CH3:27])[CH2:19][CH2:18][N:17](C(OC(C)(C)C)=O)[CH2:16][CH2:15]2)=[O:13])[CH:8]=[CH:9][CH:10]=1)([CH3:4])([CH3:3])[CH3:2].Cl>CO>[C:1]([C:5]1[CH:6]=[C:7]([NH:11][C:12]([C:14]2([CH3:27])[CH2:15][CH2:16][NH:17][CH2:18][CH2:19]2)=[O:13])[CH:8]=[CH:9][CH:10]=1)([CH3:4])([CH3:2])[CH3:3]참가 물질
4
실험 절차
tert-Butyl 4-(3-tert-butylphenylcarbamoyl)-4-methylpiperidine-1-carboxylate from step A (0.4 g, 1.07 mmol) was treated with HCl (4.0 N in dioxane, 1.3 mL, 5.34 mmol) in methanol (5.0 mL) at 50° C. for 30 minutes. The mixture was concentrated to give the title compound as the hydrochloride salt in quantitative yield. MS (ES+) [M+H]+=275.
후처리
- concentrationThe mixture was concentrated
출처 및 근거
- ORD 기록
- ord-361d2af2da5940e2b12b405634062e3a
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08193202B2
연결된 노트
불러오는 중…